
Toku Eyes
Valuation
$8.6M
2024 Revenue
$2.9M
Funding
$0
Team
19
Founded
2019
How Toku Eyes grew Toku Eyes to $2.9M revenue with a 19 person team in 2024.
Toku is creating a world focused on preventive healthcare, using the eye as a window to our health. We believe every person in the world should have access to early diagnosis of health conditions before it’s too late. How? by developing tools using AI and retinal images to enable accessible healthcare for early and accurate diagnosis of health conditions to empower everyday individuals. The retina has long been recognized as a unique window into an individual’s health, as the biomarkers present in retinal images may provide valuable insights into aging, inflammatory health, neurological health, and cardiovascular health. BioAge Not all people age equally. Every person has two ages: our chronological age (how old you are) and our biological age. Biological age (or BioAge) is a measure of how well our cells, tissues and organs are aging. Toku’s BioAge product determines a person’s biological age, which can give an indication of their overall health, by looking at vascular, metabolic, inflammatory and lifestyle indicators present in the retinal image. By knowing our BioAge earlier, we can make conscious health choices to improve our health. Unlike our chronological age, our BioAge is not fixed. BioAge uses retinal images and hence is non-invasive, time efficient, cost effective, and can be delivered by trusted healthcare providers. The retinal vasculature allows direct non-invasive visualization of the body’s microvasculature, as it is the only part of the body where scientists and clinicians can directly assess the health of an individual’s neuro-vascular tissues. Toku’s AI platform utilizes a revolutionary, patented method to evaluate more than 23 million technical parameters and 12 biological parameters in each retinal image, to produce a BioAge outcome. The AI engine has learned patterns from images from over 1.3 million retinal images to recognize the various features of health. Cardiovascular Screening (CLAiR) Cardiovascular disease is the leading caus
Last updated
Toku Eyes Revenue
In 2024, Toku Eyes's revenue reached $2.9M. Since its launch in 2019, Toku Eyes has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2024 | Toku Eyes Hit $2.9m revenue in June 2024 |
| 2019 | Launched with $0 revenue |
Toku Eyes Valuation, Funding Rounds
Toku Eyes's most recent disclosed valuation is $8.6M.
Toku Eyes is a bootstrapped Image Recognition Software startup. Founded in 2019, Toku Eyes has grown to $2.9M in revenue without raising any venture capital or outside funding.
As a self-funded Image Recognition Software SaaS company, Toku Eyes has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
Toku Eyes Employees & Team Size
Toku Eyes employs approximately 19 people as of 2026.
Toku Eyes has 19 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2024 | Reached 19 employees (June 2024) |
Customers
We do not have customer count information for Toku Eyes yet.
Frequently Asked Questions about Toku Eyes
What is Toku Eyes's revenue?
Toku Eyes generates $2.9M in revenue.
How much funding does Toku Eyes have?
Toku Eyes raised $0.
How many employees does Toku Eyes have?
Toku Eyes has 19 employees.
Where is Toku Eyes headquarters?
Toku Eyes is headquartered in San Diego, California, United States.
People Also Viewed

NextME
NextME makes it simple for businesses to manage waitlists and serve more customers. Track visits and wait times, engage your customers in real-time with a custom virtual waiting room, and grow your business like never before. NextME leverages proprietary historical data to help businesses quote more accurate wait times during peak hours. We believe in superior customer service and that waiting in line can be done virtually, not physically. NextME's digital waitlist for businesses is available to download in the App Store today: http://apple.co/1IUTQWw We're hiring! See our current opening positions here: https://bit.ly/3llzOho Need an extra hand with a product demo? Give us a call at (877) 639-8631

BluAgent
BluAgent Technologies is a fully integrated SaaS platform that streamlines and simplify the entire safety and compliance process

Filtered.ai
Filtered uses performance data to maximize the quality of your current and future workforce.

Headway Essex
Headway Essex is a charity that supports people living with acquired brain injury, ensuring they can live a fulfilling life.

Digital Horizon
Digital Horizon is a VC firm focused on backing exceptional entrepreneurs building B2B software-based solutions and marketplaces. With a presence in London, Tel Aviv and Moscow, Digital Horizon aims to seek out early-stage technology companies with the ultimate goal to assist them in building and scaling their business.

Trefis
Provider of a business analysis technology. The company provides a data analytics technology for investors and decision-makers in business that allows users to share, use, and collaborate on analysis.
Compare Toku Eyes to the industry
Toku Eyes operates across multiple industries. Browse revenue, funding, and growth data for Toku Eyes in each sector below.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .